Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.

Kim Y, Kim MO, Shin JS, Park SH, Kim SB, Kim J, Park SC, Han CJ, Ryu JK, Yoon YB, Kim YT.

Ann Surg Oncol. 2014 Aug;21(8):2684-98. doi: 10.1245/s10434-014-3531-y. Epub 2014 Mar 31.

PMID:
24682719
2.

Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.

Okabe H, Beppu T, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Jono H, Ueda M, Phd SS, Ando Y, Baba H.

Ann Surg Oncol. 2011 Apr;18(4):1175-84. doi: 10.1245/s10434-010-1391-7. Epub 2010 Nov 2.

PMID:
21042948
3.

Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.

Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, Ishikawa S, Watanabe M, Takamori H, Iyama K, Baba H.

Ann Surg Oncol. 2009 Sep;16(9):2555-64. doi: 10.1245/s10434-009-0568-4. Epub 2009 Jun 23.

PMID:
19548033
4.

Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.

Okamoto K, Tajima H, Ohta T, Nakanuma S, Hayashi H, Nakagawara H, Onishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Harada S, Wakayama T, Iseki S.

Int J Oncol. 2010 Nov;37(5):1251-9.

PMID:
20878072
5.

Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.

El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, Wilkens L, Plentz RR.

Hepatology. 2013 Mar;57(3):1035-45. doi: 10.1002/hep.26147. Epub 2013 Jan 25. Erratum in: Hepatology. 2014 Aug;60(2):771.

PMID:
23172661
6.

Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.

Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S, Wakayama T, Iseki S, Ohta T.

Int J Oncol. 2012 Aug;41(2):573-82. doi: 10.3892/ijo.2012.1499. Epub 2012 May 29.

PMID:
22664794
7.

Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.

Fingas CD, Bronk SF, Werneburg NW, Mott JL, Guicciardi ME, Cazanave SC, Mertens JC, Sirica AE, Gores GJ.

Hepatology. 2011 Dec;54(6):2076-88. doi: 10.1002/hep.24588.

8.

Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.

Gentilini A, Rombouts K, Galastri S, Caligiuri A, Mingarelli E, Mello T, Marra F, Mantero S, Roncalli M, Invernizzi P, Pinzani M.

J Hepatol. 2012 Oct;57(4):813-20. doi: 10.1016/j.jhep.2012.06.012. Epub 2012 Jun 19.

PMID:
22727731
9.

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.

Lu Z, Wang J, Zheng T, Liang Y, Yin D, Song R, Pei T, Pan S, Jiang H, Liu L.

BMC Cancer. 2014 Oct 25;14:783. doi: 10.1186/1471-2407-14-783.

10.
11.

Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.

Ohira S, Itatsu K, Sasaki M, Harada K, Sato Y, Zen Y, Ishikawa A, Oda K, Nagasaka T, Nimura Y, Nakanuma Y.

Pathol Int. 2006 Jul;56(7):381-9.

PMID:
16792547
12.

Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.

Assawasuparerk K, Vanichviriyakit R, Chotwiwatthanakun C, Nobsathian S, Rawangchue T, Wittayachumnankul B.

Asian Pac J Cancer Prev. 2016;17(2):511-7.

13.

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.

Hao XY, Cai JP, Liu X, Chen W, Hou X, Chen D, Lai JM, Liang LJ, Yin XY.

Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.

14.

Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.

Fingas CD, Mertens JC, Razumilava N, Sydor S, Bronk SF, Christensen JD, Rizvi SH, Canbay A, Treckmann JW, Paul A, Sirica AE, Gores GJ.

Hepatology. 2013 Oct;58(4):1362-74. doi: 10.1002/hep.26484. Epub 2013 Aug 6.

15.

Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.

Xiong GP, Zhang JX, Gu SP, Wu YB, Liu JF.

Neoplasma. 2012;59(4):409-15. doi: 10.4149/neo_2012_053.

PMID:
22489696
16.

Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.

Frampton G, Coufal M, Li H, Ramirez J, DeMorrow S.

Exp Cell Res. 2010 May 15;316(9):1465-78. doi: 10.1016/j.yexcr.2010.03.017. Epub 2010 Mar 25.

17.

Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.

Yu Y, Liao M, Liu R, Chen J, Feng H, Fu Z.

World J Surg Oncol. 2014 Mar 31;12:78. doi: 10.1186/1477-7819-12-78.

18.

Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.

Zhang KS, Zhou Q, Wang YF, Liang LJ.

Oncol Rep. 2013 Sep;30(3):1430-8. doi: 10.3892/or.2013.2560. Epub 2013 Jun 21.

PMID:
23799613
19.

Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration.

Hidalgo M, Amador ML, Jimeno A, Mezzadra H, Patel P, Chan A, Nielsen ME, Maitra A, Altiok S.

Mol Cancer Ther. 2006 Jul;5(7):1895-903.

20.

Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.

Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X.

J Cancer Res Clin Oncol. 2016 May;142(5):969-80. doi: 10.1007/s00432-016-2121-8. Epub 2016 Jan 29.

PMID:
26825606

Supplemental Content

Support Center